Micrologix biotech Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Micrologix biotech

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Dan Hamilton who wrote (26)	5/21/1997 9:00:00 PM
From: Dan Hamilton	of 792

Some coverage of MBI... Van Sun says UBC researcher excited Micrologix Biotech Inc MBI Shares issued 23038599 1997-05-16 close $3.7 Tuesday May 20 1997 In the News The Vancouver Sun reports on the front page of its Tuesday edition that bacteria do not have a chance when they run into one of Bob Hancock's killers, which could prove to be the first new class of antibiotics developed in 30 years. Reporter Margaret Munro says they latch on to the bacteria and quickly pry open holes in the microbes' outer membranes. University of BC microbiologist Mr Hancock says that then their guts leak out. He sees a big future for the little killers known as cationic peptides. The potent molecules promise much-needed relief from bacteria that are growing more resistant to conventional antibiotics. Mr Hancock, whose team has figured out how to mass produce peptides, which are found in minuscule amounts in almost all living things, from flies to humans, says it is really quite exciting. UBC has licensed the team's technologies to the local firm Micrologix Biotech, which is busy creating ever more potent varieties.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next